| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 1,054,031 | 1,069,123 | 1,186,644 | 1,172,351 | | Cost of Revenue | 353,362 | 304,674 | 326,698 | 267,915 | | | Gross Profit | 700,669 | 764,449 | 859,946 | 904,436 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 462,098 | 462,159 | 503,800 | 611,643 | | Non Recurring |
-
| 151,000 |
-
|
-
| | Others | 9,624 | 13,686 | 14,155 | 14,375 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 228,947 | 137,604 | 341,991 | 278,418 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (242,298) | (502,419) | (74,162) | 22,406 | | Earnings Before Interest And Taxes | (13,351) | (364,815) | 267,829 | 300,824 | | Interest Expense | 36,611 | 28,073 | 20,837 | 16,627 | | Income Before Tax | (49,962) | (392,888) | 246,992 | 284,197 | | Income Tax Expense | (18,735) | (137,488) | 92,319 | 106,574 | | Minority Interest | (46) | (51) | (91) | (159) | | | | Net Income From Continuing Ops | (31,273) | (255,451) | 154,582 | 177,464 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (31,273) | (255,451) | 154,582 | 177,464 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($31,273) | ($255,451) | $154,582 | $177,464 |
|
5.12% Nasdaq 
Income Statement
